Drilldown: Medicines - Pharmacopedia

Choose a table:

Medicines (732)

Medicines > fda max

: 50 mg/d

or Formulation-specific; ~4.8 g/d typical maximum oral

& routes: rectal

Use the filters below to narrow your results.

Mesalamine (5-aminosalicylic acid, 5-ASA) (1)

Asacol HD, Pentasa, Lialda, Apriso, Delzicol, Rowasa (rectal), Canasa (suppository) (1)

[[:Category:5-aminosalicylates|5-aminosalicylate (5-ASA)]] (1) · [[:Category:Anti-inflammatories|Anti-inflammatory]] (1) · [[:Category:IBD_medications|IBD medication]] (1)

None (1)

'"`UNIQ--vote-00000BBC-QINU`"', '"`UNIQ--vote-00000BBD-QINU`"' (1)

Active UC: Lialda 2.4-4.8 g PO once daily, Apriso 1.5 g PO once daily; maintenance 1.2-2.4 g/d; rectal Rowasa enema 4 g HS for distal disease; Canasa 1 g suppository HS for proctitis (1)

Multiple non-bioequivalent oral formulations (pH-, time-, and moisture-dependent release); rectal enema 4 g/60 mL; 1 g rectal suppository (1)

Symptomatic improvement 2-4 weeks (1)

24 hours (most ER formulations) (1)

~5-10 hours (5-ASA)'"`UNIQ--ref-00000BBE-QINU`"' (1)

Highly formulation-dependent; the goal is colonic delivery with minimal systemic exposure'"`UNIQ--ref-00000BBF-QINU`"' (1)

Generally considered safe at standard doses; benefits typically outweigh in active IBD.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)

[[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 1 result in range #1 to #1.

M

Mesalamine

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"